Strata Critical Medical, Inc.
SRTA· Nasdaq
Filed Mar 16, 2023 · 10-K · 75 days after period end · 0001779128-23-000029
| Metric | Q4 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|
| Revenue | $38.14M | $24.62M | $7.99M |
| Net Income | -$27.26M | $772.00K | -$2.36M |
| EPS Diluted | — | $0.01 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 16, 2023 · 75 d after period end